Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of dapagliflozin on impaired awareness of hypoglycemia in type 1 diabetes
2018-001569-17Phase 2Completed
- Sponsor
- Radboud University Medical Center
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of dapagliflozin in diabetes mellitus type 1 (T1D), sponsored by Radboud University Medical Center. Primary endpoint: Maximal hypoglycemia symptom score. Started Aug 2018; status: completed.
02
Drugs
dapagliflozin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2018-001569-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001569-17.